Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera J Evtimov

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 5, 2022
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategiesVan To, Vera J Evtimov, Graham Jenkin, et al.
Immunological Investigations|August 1, 2025
Engineering TAG-72 and CD30 CAR-T Cells for T Cell MalignanciesVan To, Vera J Evtimov, Runzhe Shu, et al.
Translational Oncology|July 29, 2022
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroidsAnisha B Suraiya, Vera J Evtimov, Vinh X Truong, et al.
Molecular Therapy Oncolytics|February 22, 2021
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancerRunzhe Shu, Vera J Evtimov, Maree V Hammett, et al.
Molecular Therapy. Oncology|April 10, 2025
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancerVera J Evtimov, Nhu-Y N Nguyen, Maree V Hammett, et al.
Heliyon|September 12, 2024
Targeting TAG-72 in cutaneous T cell lymphomaVera J Evtimov, Maree V Hammett, Aleta Pupovac, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 5, 2022
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategiesVan To, Vera J Evtimov, Graham Jenkin, et al.
Immunological Investigations|August 1, 2025
Engineering TAG-72 and CD30 CAR-T Cells for T Cell MalignanciesVan To, Vera J Evtimov, Runzhe Shu, et al.
Translational Oncology|July 29, 2022
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroidsAnisha B Suraiya, Vera J Evtimov, Vinh X Truong, et al.
Molecular Therapy Oncolytics|February 22, 2021
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancerRunzhe Shu, Vera J Evtimov, Maree V Hammett, et al.
Molecular Therapy. Oncology|April 10, 2025
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancerVera J Evtimov, Nhu-Y N Nguyen, Maree V Hammett, et al.
Heliyon|September 12, 2024
Targeting TAG-72 in cutaneous T cell lymphomaVera J Evtimov, Maree V Hammett, Aleta Pupovac, et al.
Pageof 1